Daiwa Securities Group Inc. Legend Biotech Corp Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 294 shares of LEGN stock, worth $9,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294
Previous 7,726
96.19%
Holding current value
$9,913
Previous $263,000
96.2%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
59.9MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$233 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$202 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$193 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$127 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$99.9 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.64B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...